Rx Industry Research Foundation Proposed By Sloan-Kettering Oncologist
Executive Summary
Pharmaceutical companies should establish a collaborative foundation to fund basic scientific research to support oncologic drug development, Memorial Sloan-Kettering Cancer Center Director of Breast Cancer Programs Larry Norton, MD, said